Clinical Trial Update: Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance therapy with pegylated interferon alfa-2b (PegIntron) after autologous peripheral blood stem cell transplant in multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Multiple Mieloma | Phase 2 | Status: UNKNOWN